Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Weight loss represents a significant secondary goal alongside diabetes management for many who select this option
The culmination came with Wegovys June 4, 2021, approval of semaglutide 2.4 mg specifically for chronic weight management
The total sales of Eli Lilly's two brands of tirzepatide, Mounjaro (for blood - sugar control) and Zepbound (for weight loss), were approximately $16.5 billion during the same period
No, tirzepatide is not a treatment for Cushing's syndrome or conditions of cortisol excess
US$ 26.63
US$ 27.31
US$ 23.03
US$ 26.97
US$ 20.98
